Page last updated: 2024-11-05

trimethoprim and Botulism

trimethoprim has been researched along with Botulism in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Botulism: A disease caused by potent protein NEUROTOXINS produced by CLOSTRIDIUM BOTULINUM which interfere with the presynaptic release of ACETYLCHOLINE at the NEUROMUSCULAR JUNCTION. Clinical features include abdominal pain, vomiting, acute PARALYSIS (including respiratory paralysis), blurred vision, and DIPLOPIA. Botulism may be classified into several subtypes (e.g., food-borne, infant, wound, and others). (From Adams et al., Principles of Neurology, 6th ed, p1208)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Swenson, JM1
Thornsberry, C1
McCroskey, LM1
Hatheway, CL1
Dowell, VR1

Other Studies

1 other study available for trimethoprim and Botulism

ArticleYear
Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.
    Antimicrobial agents and chemotherapy, 1980, Volume: 18, Issue:1

    Topics: Anti-Bacterial Agents; Botulism; Cefoxitin; Cephalothin; Clindamycin; Clostridium botulinum; Erythro

1980